Home Precision Medicine Genome Editing

Genome Editing

Latest
Health care, Blood test
Genome Editing

What Does It Take to Drive Genomics into the Clinic?

Gemome Sequence Map
Genome Editing

Big Data and Clinical Genomics

Editas Medicine has won FDA approval of its IND application for its Leber Congenital Amaurosis type 10 (LCA10) candidate EDIT-101
Genome Editing

FDA Approves IND for Editas’ CRISPR Genome Editing Treatment EDIT-101

Illumeo’s Findings Presenter integrates patient information and enables tailored output
Genome Editing

Keeping Up with the Genomes

[Source: Stocktrek Images / Getty Images]
Genome Editing

Resolution Revolution: Single-cell Sequencing Techniques Provide Significant Advances

Translating tools and technologies toward clinical use is the focus of the NIH's new Somatic Cell Genome Editing program
Genome Editing

NIH to Fund Translational Research in Somatic Cell Genome Editing

Source: vchal/Getty Images
Genome Editing

First Patient Treated with Sangamo In Vivo Genome Editing Therapeutic

The Merkin Institute for Transformative Technologies will fund early-stage ideas for novel technological approaches to treating disease. [Source: © 4designersart/Fotolia]
Genome Editing

Broad Institute Launches Effort to Fund Transformative Technologies

Poseida researchers in the lab.
Genome Editing

A Dose of CRISPR: Can Gene Editing Cut It in the...

The University of California and other holders of a European CRISPR patent file a brief with the U.S. Court of Appeals for the Federal Circuit to overturn a February decision by the Patent Trial and Appeal Board siding with the Broad Institute of MIT and Harvard in the dispute over who invented the gene-editing technology [Source: Molekuul/Getty Images]
Genome Editing

UCal, European CRISPR Patent Holders Appeal U.S. Ruling

Load more

New Products

View More
Load more

News Briefs

View More
Load more
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up